These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 810812)

  • 1. Thyrotropin releasing hormone (TRH): DOPA potentiation and biogenic amine studies.
    Plotnikoff NP; Breese GR; Prange AJ
    Pharmacol Biochem Behav; 1975; 3(4):665-70. PubMed ID: 810812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolyl-leucyl-glycine amide (PLG) and thyrotropin-releasing hormone (TRH): DOPA potentiation and biogenic amine studies.
    Plotnikoff NP
    Prog Brain Res; 1975; 42():11-23. PubMed ID: 730
    [No Abstract]   [Full Text] [Related]  

  • 3. Action of two hypothalamic factors (TRH, MIF) and of angiotensin II on the behavioral effects of L-DOPA and 5-hydroxytryptophan in mice.
    Huidobro-Toro JP; De Carolis AS; Longo VG
    Pharmacol Biochem Behav; 1974; 2(1):105-9. PubMed ID: 4364044
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of biogenic amines and TRH on release of prolactin and TSH in the rat.
    Chen HJ; Meites J
    Endocrinology; 1975 Jan; 96(1):10-4. PubMed ID: 803259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DOPA potentiation in ablated animals and brain levels of biogenic amines in intact animals after prolyl-leucylglycinamide.
    Plotnikoff NP; Minard FN; Kastin AJ
    Neuroendocrinology; 1974; 14(5):271-9. PubMed ID: 4858836
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation by TRH of the effect of antidepressants in the forced-swimming test, involvement of dopaminergic and opioid systems.
    Reny-Palasse V; Constans M; Rips R
    Br J Pharmacol; 1989 May; 97(1):197-205. PubMed ID: 2541855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cholecystokinin on thyrotropin releasing hormone (TRH)-induced serotonin potentiation in rats.
    Itoh S; Katsuura G
    Jpn J Physiol; 1982; 32(1):145-8. PubMed ID: 6281503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyrotropin releasing hormone: enhancement of dopa activity by a hypothalamic hormone.
    Plotnikoff NP; Prange AJ; Breese GR; Anderson MS; Wilson IC
    Science; 1972 Oct; 178(4059):417-8. PubMed ID: 4627781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensification of central catecholaminergin and serotonergic processes by the hypothalamic factors MIF and TRF and by angiotensin II.
    Huidobro-Toro JP; Scotti de Carolis A; Longo VG
    Pharmacol Biochem Behav; 1975; 3(2):235-42. PubMed ID: 238221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation by TRH of the effect of imipramine on the forced-swimming test.
    Reny-Palasse V; Rips R
    Br J Pharmacol; 1985 Jun; 85(2):463-70. PubMed ID: 2992664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of drugs that modify brain biogenic amine concentrations on thyroid activation induced by exposure to cold.
    Onaya ; Hashizume K
    Neuroendocrinology; 1976; 20(1):47-58. PubMed ID: 180445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of trazodone on behavior and brain amine content of mice.
    Massotti M; De Carolis S; Longo VG
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):133-9. PubMed ID: 812658
    [No Abstract]   [Full Text] [Related]  

  • 14. Thyrotropin-releasing hormone: hyperactivity and mesolimbic dopamine system in rats.
    Miyamoto M; Narumi S; Nagai Y; Shima T; Nagawa Y
    Jpn J Pharmacol; 1979 Jun; 29(3):335-47. PubMed ID: 119887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is a dopaminergic system involved in thyrotropin releasing hormone induced hyperthermia and in its potentiation by amphetamine?
    Rips R; Desiles M; Puech AJ
    Prog Neuropsychopharmacol; 1979; 3(4):337-44. PubMed ID: 45568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of L-dopa on behavior and on brain amines in mice treated with 6-hydroxydopamine.
    Barnes L; Cann F; Karczmar AG; Kindel G; Longo VG
    Pharmacol Biochem Behav; 1973; 1(1):35-40. PubMed ID: 4775581
    [No Abstract]   [Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone and thyrotropin-releasing hormone: distribution and effects in the central nervous system.
    Wilber JF; Montoya E; Plotnikoff NP; White WF; Gendrick R; Renaud L; Martin JB
    Recent Prog Horm Res; 1976; 32():117-59. PubMed ID: 822482
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoamine mediation of the morphine-induced activation of mice.
    Carroll BJ; Sharp PT
    Br J Pharmacol; 1972 Sep; 46(1):124-39. PubMed ID: 4263794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRH on rat conditioned avoidance behavior: interaction with brain catecholamines.
    Mora S; Nasello AG; Fieschi L
    Pharmacol Biochem Behav; 1980 Jul; 13(1):137-9. PubMed ID: 6773073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of various amines on TRH contents in rat brain (author's transl)].
    Mitsuma T; Hirooka Y; Nihei N
    Nihon Naibunpi Gakkai Zasshi; 1976 Aug; 52(8):806-13. PubMed ID: 138603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.